Manufacturing

Articles

This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.

Media Requirements for Different Cell Sources

New data highlights ability of the SQZ  cell therapy platform to preserve cellular functions.

SQZ Biotech Discusses Potential Benefit of Cell Therapy Platform

A project funded by BioProNET will investigate optimization for bioprocessing of gene therapy vectors using hydrodynamic fluid flow fields.

Cobra Biologics and the University of Leeds Collaborate on Viral Vector Bioprocessing

A statement from FDA Commissioner Scott Gottlieb and Deputy Commissioner Anna Abram detailed FDA’s new plan to advance plant and animal biotechnology innovation.

FDA Announces Plan to Advance Biotech Innovation

The acquisition will allow Lonza to further develop technology for scalable autologous cell-therapy manufacturing.

Lonza Acquires a Controlling Stake in Octane Biotech for Cell Therapy Technology

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

AGC Biologics Adds Mammalian Production Capacity in Japan

The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.

Janssen, Arrowhead Enter $3.7-Billion Partnership to Treat Hep B

The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.

University College London and Pall Biotech Open Research and Training Center

Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.

Manufacturing, Biologic Drugs